Na Yeon Kim

Insider Reports History

Entity
Individual
Location
C/O Neurobo Pharmaceuticals, Inc., 177 Huntington Avenue, Suite 1700, Boston, MA
Signature
/s/ Phillip D. Torrence, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Na Yeon Kim:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NeuroBo Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 101K $318K $3.13 Jul 27, 2023 Direct
NeuroBo Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 96.4K $302K $3.13 Jul 27, 2023 Held by The E&Healthcare Investment Fund II
NeuroBo Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 62.2K $195K $3.13 Jul 27, 2023 Held by The E&Healthcare Investment Fund No. 7
NeuroBo Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 37.4K $117K $3.13 Jul 27, 2023 Held by The E&Healthcare Investment Fund No. 6
NeuroBo Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 4.67K $14.6K $3.13 Jul 27, 2023 Held by E&Investment Inc.

Insider Reports Filed by Na Yeon Kim

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NRBO NeuroBo Pharmaceuticals, Inc. Jul 27, 2023 2 $0 4 Jul 28, 2023 Director, 10%+ Owner
NRBO NeuroBo Pharmaceuticals, Inc. Jul 26, 2022 1 $0 4/A Jul 28, 2023 Director, 10%+ Owner
NRBO NeuroBo Pharmaceuticals, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director, 10%+ Owner